#44 Victory or false promises?

Hey friends,

This week, more money is being thrown into startups that are harnessing the power of sensors and diagnostic testing to support patients in the comfort of their homes, Amazon wants to get you up and moving to improve your “Movement Health” and is it all good news for patients following approval of the first Alzheimer’s drug in the US since 2003?

News Bites 🥪

🏠 At-home diagnostic testing startup, LetsGetChecked secures $150 million to meet “unprecedented” demand

🤖 HumanFirst raises $12 Million to move clinical trials and medical care into patients’ homes using sensors

🖐 Can wearable sensors advance from monitoring patients with Parkinson’s to providing a more tailored helping hand?

💪 Improve your “Movement Health” with Amazon’s fitness service Halo

💊 Victory or false promises for patients as FDA approves first new Alzheimer’s drug since 2003

What to Listen to 🔊

The Healthtech Podcast: The Story of bit.bio with CEO Dr Mark Kotter

This week James is joined by Dr Mark Kotter, a neurosurgeon, stem cell biologist and serial entrepreneur. He is the founder and CEO of bit.bio whose ‘opti-ox’ technology allows for the efficient and consistent production of human cells for use in research, drug development, and cell therapy…

The Impact Interview: Reimagining a future where everyone survives cancer

In this episode, Matt Venning talks with Dr Bhavagaya Bakshi, CEO and co-founder of C The Signs. C The Signs is a digital tool, primarily for doctors, to support the early identification of patients at risk of cancer. Using AI and advanced algorithms, the platform can identify which cancer or cancers a patient is at risk of and the most appropriate next step – all in less than 30 seconds. Earlier detection and diagnosis results in better outcomes for patients…

Opportunities 💰

1️⃣  Oto, a treatment platform for tinnitus patients, is looking for a Marketing and Community Manager